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1. Introduction 
Autoimmune Hashimoto’s thyroiditis involves painless enlargement of the thyroid, which, 
in histopathological analysis, is characterised by diffuse lymphocytic infiltrations, fibrosis, 
and atrophic changes. It is a diffuse process, a combination of epithelial cell destruction, 
lymphocyte infiltrations, and fibrosis. The incidence of Hashimoto’s thyroiditis ranges 
between 0,3 and 1,5 per 1000 persons. It is diagnosed 15-20 times more frequently in females 
than in males. The forms of Hashimoto’s thyroiditis include: euthyroid goitre, and goitre in 
subclinical or clinical hypothyroidism, hypothyroidism without goitre, silent thyroiditis, 
postpartum thyroiditis, alternating hyperthyroidism and hypothyroidism [Weetman 
&McGregor 1994]. 
Hashimoto’s thyroiditis is often associated with type I diabetes, coeliac disease and other 
autoimmune diseases. It is one of the components of the autoimmune polyglandular 
syndrome.  
In histopathological investigations of Hashimoto’s thyroiditis, the follicular epithelial cells in 
the thyroid are large and often eosinophilic; they are the so-called Hurthle or Askenazy cells 
packed with mitochondria. Lymphocyte clusters present between the follicles form typical 
lymphoid follicles in some sites. Infiltrations contain numerous plasma cells. In Hashimoto’s 
thyroiditis, the immunological attack appears to be destructive, rather than stimulating, as 
in Graves’ disease. Two variants of Hashimoto's thyroiditis have been reported so far: 
atrophic – related to gene HLA-DR3 inheritance, and hypertrophic – involving goitre 
enlargement associated with HLA-DR5 [Weetman, 2004]. A study of autoimmune 
thyroiditis in monozygotic twins demonstrated environmental factors inducing 
development of the disease [Brix et al., 2000]: high iodine intake, selenium deficiency, 
smoking, infectious diseases, e.g. hepatitis C, and some drugs [Duntas, 2008]. Prolonged 
exposure to iodine leads to enhanced iodination of thyroglobulin, which increases its 
antigenicity and initiates autoimmune processes in genetically predisposed individuals. 
Selenium deficiency causes a decrease in the activity of selenoproteins, including 
glutathione peroxidise, which leads to an increase in the concentration of hydrogen 
peroxide and development of inflammatory processes.  
Classical histopathological descriptions of the thyroid in Hashimoto’s thyroiditis emphasise 
the fact that the changes include destruction of thyrocytes, lymphocytic infiltration, and 
fibrosis. 
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2. The course of the immune response in Hashimoto's thyroiditis 
2.1 Antigen presentation 
Stimulation of the immune system depends on maturity of dendritic cells. Immature 
dendritic cells are characterized by expression of small numbers of co-stimulatory molecules 
and proinflammatory cytokines; they may also cause anergy. Maturing dendritic cells 
display significantly higher expression of MHC class II and co-stimulatory molecules, but 
low levels of proinflammatory cytokines. Only mature dendritic cells can induce regulatory 
T cells [Jonuleit et al., 2001; Menges et al., 2002; Gad et al., 2003; Wakkach et al., 2005]. 
Antigen presenting cells are more frequently found in Hashimoto’s thyroiditis than in 
healthy thyroid glands or individuals with non-autoimmune thyroid diseases (simple goitre, 
non-toxic nodular goitre) [Ben-Skowronek et al., 2008, 2011]. No mature dendritic cells 
presenting MHC class II antigens have been found in thyroid preparations. The 
investigations conducted by Kimura et al. have indicated that MHC class II antigens may be 
expressed on thyrocytes in the autoimmune thyroid inflammation. Our own research has 
shown a positive reaction with the monoclonal antibody CD1a specific for dendritic cells in 
some thyrocytes. This is not sufficient to initiate the autoimmune response, but sufficient to 
sustain it [Kimura et al., 2004]. 
2.2 Development of immunological reaction in the thyroid gland  
Lymphatic follicles appear inside the thyroid gland in the course of Hashimoto’s thyroiditis. 
The study of Armengol et al. has demonstrated higher levels of lymphokines and their 
ligands responsible for lymphocyte migration, settlement, and formation of lymphoid 
follicles (lymphotoxin α, lymphotoxin β, CC chemokine ligand (CCL)), and CXC (CXCL 12, 
CXCL13) chemokine ligands). Moreover, in response to inflammatory cytokines, thyrocytes 
can produce CXCL12. Tissue stress caused by viral or bacterial inflammation is likely to lead 
to formation of lymphoid follicles in the thyroid [Armengol, et al., 2003]. Production of 
cytokine ligands for CXCL21, CXCL 22, and CXCL 13 by thyrocytes is correlated with the 
level of anti-thyroid antibodies, and thus, directly with the inflammatory response in the 
thyroid [Armengol  et al., 2003]. 
From the physiological point of view, lymphoid follicles are small structures in which 
processes of somatic hypermutation, maturation of immune affinity receptors, switching of 
antibody isotypes (e.g. from IgM to IgG), and receptor control take place. Autoreactive T 
cells arise de novo in the germinal centres; here operates the mechanism sustaining 
tolerance - apoptosis of autoreactive lymphocytes [Pulendrav et al., 1997, Janevay et al., 
2002]. In autoimmune diseases of the thyroid, muscles, and joints as well as in Sjögren's 
syndrome and autoimmune alveolitis, the ectopic lymphoid tissue is arranged in lymphoid 
follicles in non-lymphatic organs, which do not contain physiological, growing lymphoid 
tissue [Crawford et al.1983, Schroeder et al., 1996, Wallace et al.1996, Shione et al  1997, Stott 
et al 1998, Itoh et. al 2000, Sims et al,. 2001]. The function of this lymphoid tissue, sometimes 
defined as tertiary lymphoid tissue (primary tissues - thymus and bone marrow, secondary - 
lymphatic glands and organs), is unclear [Weetman et al. 1994, Ruddle et al. 1999, Armengol 
et al , 2001]. The structure of the ectopic lymphoid follicles in the thyroid is similar to that of 
typical lymphoid follicles in lymphoid organs: they consist of a germinal centre and a 
peripheral zone (mantle zone) containing lymphocytes B and T, and dendritic cells. An 
analysis of immunoglobulin gene rearrangement (RAG1 and RAG2) has confirmed the 
possibility of formation of high endothelial venules in lymphoid follicles and production of 
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cytokines responsible for lymphocyte migration and settlement, which would trigger an 
autoimmune reaction [Armengol et al., 2001]. TG Ab, TPO Ab and TRAK  anti-thyroid 
antibodies are produced in B cells in the lymphoid follicles [Armengol et al., 2001]. High 
levels of antibodies against thyroglobulin (TG Ab) and thyroperoxidase (TPO Ab) are 
detected in the serum of patients with Hashimoto’s thyroiditis. These antibodies are 
regarded to have cytotoxic activity. However, investigations of thyroids of foetuses from 
mothers with Hashimoto’s thyroiditis did not show the expected damage. Hypothyroidism 
was observed only in some children.    
T cells originating from mice immunized with TPO strongly react with sequence 540-559; 
immunisation of mice with this peptide results in development of hypothyroidism and 
thyroiditis. Peptide 540-559 is probably a key factor in the immune response against TPO 
[Kawakami et al. 1992]. Natural HLA-DR-associated peptides have also been identified; they 
are present in the colloid, and some of them derive from thyroglobulin [Ng et al., 2006]. A 
larger proportion of lymphocytes binding to thyroglobulin are present in the thyroid than in 
peripheral blood [Heuer et al., 1996]. Being the major stimulatory antigen, thyroglobulin is 
indispensable for T cell response [Sugihara et al., 1993]. The severity of autoimmune 
reactions following immunization with thyroglobulin has been observed in transgenic mice 
producing IL-12 [Kimura et al.,2005].  
Immune reactions involving T cells are controlled by certain T lymphocyte subpopulations: 
CD4 + Treg and natural killer lymphocytes are employed in the control of the magnitude 
and class of the immune response, while lymphocytes CD8 + are responsible for recognition 
for self- and non-self- antigens [Jang et al., 2006].  
A slightly larger number of CD4 + cells have been observed in Hashimoto’s thyroiditis than 
in non-autoimmune thyroid diseases; however, the number was statistically significantly 
lower than in Graves' disease [ Ben-Skowronek et al., 2007,2008]. The studies of McLachlan 
suggest that the reduction in the number of Treg cells (particularly CD25) induces 
lymphocyte infiltration in the thyroid accompanied by transient or permanent 
hypothyroidism [Mc Lachlan et al., 2007]. 
Animal studies have shown that depletion of CD4 + CD25 + Treg in mice increases 
susceptibility to thyroiditis by enhancement of the immune reaction against thyroglobulin 
and exacerbates the existing thyroiditis, whereas an increase in the number of CD4 + CD25 
+ T cells restores resistance to thyroiditis [Morris et al., 2006,2007, Nagayama ey al. 2007]. It 
appears that an insufficient percentage of CD4 + T cells in Hashimoto's disease is the cause 
of the destructive autoimmune reaction in the thyroid. 
Suppressor/cytotoxic lymphocytes CD8 + have been found among thyrocytes in thyroid 
follicles, in lymphatic infiltrations and in the lymphoid follicles of the mantle zone. 
Glycoprotein CD8 present on the surface of cytotoxic lymphocytes may bind to the class I 
MHC molecule, which leads to activation of T cells CD8+. This activation is also dependent 
on co-stimulatory proteins binding to antigen CD28 (the so-called two-signal model). Once 
activated, cytotoxic lymphocytes may secrete cytotoxins, and granzymes and granulysins.  
They perforate the cell membrane and form pores, which induces apoptosis of the target 
cell. Another pathway leading to apoptosis is activation of the Fas ligand [Iannacone et al., 
2005,2006, Subramanian et. al., 2005]. Hypothyroidism in patients with autoimmune 
thyroiditis is associated with apoptosis of alveolar epithelial cells induced by cytokines. 
Expression of Fas ligand on thyrocytes of patients with Hashimoto thyroiditis and a weak 
reaction for Bcl-2 have been detected, which suggests cytokine-induced apoptosis 
[Kawakami et al., 1996, Mitsiiades et al.,1998, Stassi et al., 2002]. TPO-specific T cells cause 
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destruction through cytotoxic mechanisms involving CD4+ and CD8 + cells or programmed 
Fas- TNF-alpha-induced  apoptosis [Stassi et al., 2002]. In Hashimoto's disease, damaged 
thyrocytes in contact with CD8 + T lymphocytes may be observed in the light microscope. 
The electron microscopy has shown contact sites of lymphocytes with thyrocytes located in 
the thyroid follicular epithelium. Polarization of endolysosomes near the site of contact has 
been detected in the lymphocytes which displayed the T-cell phenotype of and CD8 + 
location. Similar observations of cultured CD8 + and dendritic cells in experimental 
conditions were conducted by Gardella et al. [Gardella et al., 2001]. The studies of  Negrini 
et al. [Negrini et al.,2006] have indicated possible presence of the GITR (Glucocorticoid-
Induced TNF-Like Receptor) antigen on the surface of CD8 + T cells, which would render 
them as regulatory Treg cells. Therefore, it is believed that cytotoxic T cells, K (killer) 
lymphocytes, NK (natural killer) cells, and regulatory (Treg) or suppressor T cells may play 
an important role in autoimmune thyroid damage. Some studies indicate the ability of T 
cells to transfer thyroid autoimmune processes, both in animals with experimental 
autoimmune thyroiditis and patients who have undergone bone marrow transplantation 
[Kawakami et al.,, 1992, Ng et al., 2006, Drabko et. al., 2006].  
Active lymphocytes B CD79alfa+ and antibody-producing plasma cells were found in a 
small percentage of thyroids from healthy children (4,11%), in the colloid goitre (1,83%) and 
the nodular goitre (5,22%). The largest number of CD79 alpha+ lymphocytes was observed 
in thyroid specimens from patients with Hashimoto’s thyroiditis (average 31,65%) In 
lymphatic infiltrates, plasma cells constituted almost half of the cells (46,67%), and 
amounted to 17,23% in the thyroid parenchyma. Foci of damaged thyroid follicles and 
numerous fibroblasts and collagen bands have been observed at the plasma cell 
accumulation sites. The thyroid glands in children with Hashimoto’s thyroiditis displayed 
characteristics of lymphocyte activation, the so-called blastic transformation, consisting in 
an increase in the volume of the cell and, particularly, of the nucleus, appearance of nucleoli 
and an increase in the cytoplasm volume through enlargement of the rough endoplasmic 
reticulum, in which antibody production takes place [Ben-Skowronek et al., 2007].  
Thyrocytes in Hashimoto’s thyroiditis are cuboidal or flat. The thyroid cells exhibit damage. 
Cell nuclei are often folded; secretory vesicles are sporadically present in the apical pole 
(sometimes there are no vesicles); and swollen mitochondria are present in the basal pole. The 
swollen part of thyrocytes without microvilli or with single microvilli projects into the lumen 
of the follicle. The basal membrane is thickened. Plasma cells, lymphocytes and fibroblasts are 
visible among the thyroid follicles. At the lymphoid infiltration sites, the lymphoid cells 
separate the thyroid epithelium from the basal membrane of the capillary blood vessels. 
Lymphocytes are often in direct contact with plasma cells. Plasma cells filled with 
concentrically arranged layers of the rough endoplasmic reticulum adhere to the basal 
membrane of the thyroid follicle and the surrounding thyrocytes. The thick, electron dense 
basal membrane contains numerous collagen fibres. The adjacent cytoplasmic membrane does 
not exhibit characteristic folds. The fibrous basal membrane hinders blood flow in the capillary 
blood vessels and deformed erythrocytes can be seen in their lumen. The exchange of nutrients 
and oxygen between thyrocytes, the interstitium, and blood vessels is impeded [Fig. 1]. 
3. Apoptosis in autoimmune thyroid diseases 
Apoptosis is a physiological form of cell death resulting from the need of multicellular 
organisms to maintain balance between dividing and dying cells. Typical morphological 
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Fig. 1. A markedly thickened basal membrane of the thyroid follicle containing collagen 
fibres impedes thyrocyte contact with the capillary vessel lumen.  In the basal membrane is 
present lymphocyte  (phenotype lymphocyte T). The thyrocytes exhibit signs of damage of 
thyroid follicular cells– swollen mitochondria, dilated cisterns of the rough endoplasmic 
reticulum, absence of secretory granules, and atrophy of microvilli. Transmission Electron 
Microscope  Magn. 10 000x. 
changes in cells that received the signal to begin the apoptotic process include folding of the 
cell membrane, condensation of cytoplasm and cellular organelles, disappearance of the 
mitochondrial membrane, shrinkage of the nucleus, and condensation of chromatin 
[Yamazaki  et al., 2000, Lorenz et al., 2005]. 
Apoptosis can be initiated by T cells through two pathways: 
 by perforins secreted by lymphocytes into the junctions between lymphocytes and 
target cells; they perforate the cell membrane and form pores thus inducing osmotic 
lysis of the cell; simultaneously, granzymes B activate the caspase cascade, which leads 
to cell apoptosis; 
 the Fas ligand and TNF-related apotosis induced ligand (TRAIL) secreted by 
lymphocytes stimulate the so-called death receptors on the cell surface causing 
activation of caspase cascade through caspase 8 and 10. 
Lymphocytic infiltration and antibodies secreted by plasma cells lead to destruction of 
thyrocytes, but actively stimulate the production of collagen by fibroblasts. As a result, large 
amounts of collagen accumulate in the follicular and vascular basal membranes. In the final 
stage of the process, thyrocytes are destroyed via apoptosis. Typical signs of cell apoptosis 
are visible: chromatin condensation in the nuclei of thyroid epithelial cells, condensation of 
the cytosol and swelling of the mitochondria [Fig.2]. 
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Fig. 2. The last phase of destruction of the thyroid in Hashimoto’s thyroiditis. The thyrocytes 
are damaged due to apoptotic processes. Plasma cells and lymphocytes predominate in the 
interstitium. The fibroblast migrates to this place and produces collagen fibres. Transmission 
Electron Microscope. magn. 5000x. 
Various phases of thyrocyte death were visible at the lymphocyte infiltration sites; apoptosis 
was caused by active plasma cells and lymphocytes of the large granular lymphocyte 
phenotype (LGL) [Fig.2] Ultrastructural investigations have revealed that the reaction 
between lymphocytes and plasma cells producing antibody results in thyrocyte damage, 
which, in turn, changes the permeability of cell membranes and intracellular membranes 
and leads to accumulation of water in the endoplasmic reticulum cisterns in the 
mitochondria and cytoplasm. Consequently, the cell is enlarged, microvilli disappear, and 
swollen mitochondria occupy the basal pole of thyroid cells causing cell staining with acidic 
dyes. At the same time, electron-dense substances (probably antibodies) are deposited in the 
follicular basal membrane. In response, large amounts of collagen are secreted around the 
damaged follicles. Communication between the lumen of capillary vessels and thyrocytes is 
impeded; hence, the transport of oxygen, nutrients, and substrates for production of thyroid 
hormones is inhibited. The thyrocyte metabolism is decelerated, and production of hormone 
and protein colloid is disrupted. Thyrocytes gradually die and exfoliate into the follicle 
lumen. Lymphocytes migrate to replace them and form lymphoid follicles. Fibroblast bands 
producing collagen fibres penetrate the site as well.  
The contact between lymphocytes and thyrocytes in Hashimoto's thyroiditis forms an 
immunological synapse, which has been described as a specialized intercellular connection 
between T cells and antigen presenting cells [Paul  et al., 1994, Dustin et al., 1999, Grakoui et 
al., 1999]. 
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Fig. 3. Junction between the lymphocyte and plasma cell in Hashimoto’s thyroiditis. 
Electron-dense (probably protein) substance is visible in the intercellular space. N – cell 
nucleus, RER -  rough endoplasmic reticulum, L – lysosome, CM – cell membrane. 
Transmission Electron Microscope  magnification 25 000x 
The immunological synapse consists of a central zone containing antigen receptors and a 
surrounding ring of adhesion molecules [Dustin, 2002]. Lymphocytes form projections – 
lamellipodia – and form junctions with the cell membrane of thyrocytes. Presumably, it is at 
these sites that antigen presentation by thyrocytes occurs [Bromley et al.,  2001]. Recent 
studies demonstrate different types of immunological synapses: cytotoxic [Dustin  et al., 
2010] and transitory (the so-called kinapses) [Dustin et al. 2007, 2010]. Observations of the 
interaction between lymphocytes and other thyroid cells in the course of AITD indicate 
possible formation of analogous junctions between thyrocytes and lymphocytes, i.e. 
cytotoxic synapses in Hashimoto’s thyroiditis. This implies that lymphocytes secrete 
granzymes and other cytotoxic substances leading to cell damage.  
The junctions of plasma cells with thyrocytes are large adhesion zones with thyrocyte 
apoptosis visible nearby [Fig.3]. The junctions between plasma cells and fibroblasts, 
however, are associated with production of collagen fibres. In Hashimoto's thyroiditis, 
numerous junctions between lymphocytes and plasma cells in the form of adhesion zones 
and spaces have been detected, into which medium electron-density substances (probably 
proteins) were secreted [Fig.3]; there are also synapses between young and mature 
lymphocytes T and B in the lymphoid follicles.  
N 
Lymphocyte 
 
RER 
CM 
* 
Plasma cell 
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Such cell junctions occur mainly in the lymphoid nodes. Very tight junctions are visible 
between lymphoblasts and B cells, which are phenotypically similar to plasma cells. 
Immunological synapses have been found also between lymphocytes [Ben-Skowronek in 
press] 
In Hashimoto's disease, activation of apoptotic processes is also associated with activation of 
Th1 cells, which enhance the activity of caspase and apoptosis through production of IFN-γ. 
While reduction in the number of CD4 + cell subsets in the thyroid parenchyma has been 
reported both in our own study and in animal models of the disease [Sugihara et al., 1993], 
an increase in the number of active CD4 + IL-4 + was observed in the peripheral blood 
[Maziotti et al., 2003]. However, no correlation has been found between the number of CD4 
+ T cells in the thyroid and the antiperoxidase antibody levels in serum [Watanabe et al., 
2002, Pandit et al., 2003].  
Antibody-dependent cell-mediated cytotoxicity (ADCC) plays an important role in 
development of Hashimoto's thyroiditis, whereas complement-dependent cytotoxicity (CDC) 
exerts a lesser effect. The thyroid peroxidase antigen evokes the reaction [Czarnocka et al., 
1985, Estienne et al., 2002, Guo et al., 2005 Rebuffat et al., 2006, Ng et al., 2004, 2006]. TPO Ab 
has been detected in 90% of Hashimoto’s thyroiditis patients [Rappaport et al.,  2001]. Anti-
TPO antibodies are various isotypes of the IgG antibodies. Anti-peroxidase antibodies TPOAb 
can damage thyrocytes through the ADCC and CDC mechanisms. The cytotoxic ADCC 
mechanism depends on the interaction between the target cell, antibody and effector cell. 
Monocytes, which due to FcγRI receptors are effector cells activated by TPOAb, can affect T 
cells and lead to destruction of thyrocytes [Rebuffat et al.,2008]. FcγRIII are present on Natural 
Killer cells and FcγRII on monocytes and neutrophils. All FcγR fragments are involved in the 
ADCC reaction [Rebuffat  et al., 2008]. The investigations of Giancotti and Williams et al. 
suggest that integrins β2 may participate in cytotoxic reactions involving FcγR [Giancotti et al., 
1999, Williams et al., 1999]. The study of Rebufatt et al. [Rebuffat  et al., 2008], however, 
indicates involvement of two monocytic cell lines in this process. 
It has not been sufficiently documented yet whether specific IgG antibody subclasses take 
part in thyrocyte damage [Metcalfe 1997, Guo 1997]. Xie L-D et al. investigated the 
occurrence of anti-TPO IgG subclasses and found that IgG1 was present in 70.2%, IgG2 in 
35.1%, IgG3 in 19.6%, and IgG4 in 66.1% of patients; increased proportion of IgG2 
predisposes to thyroid damage and hypothyroidism [Xie et al., 2008].  
Metcalfe et al. found no correlation between the IgG subclasses and thyrocyte damage in 
vitro [Metcalfe et al.,  1997], whereas Guo et al. demonstrated that thyrocyte damage is 
associated with subclass IgG1 [Guo et al.,  1997]. Recent studies conducted by Rebuffat et al. 
[Rebuffat et al., 2010, Pappenwali et al., 2010] indicate that anti-TPO antibodies exhibit 
moderate activity in the ADCC process and can be used in the new methods of treatment of 
papillary thyroid cancer, the cells of which show expression of TPO.  
Thyrocyte damage continues and is potentialized by the CDC reaction [Rebuffat et al., 2008]. 
Complement component C4, hyperexpressed on the surface of thyrocytes in Hashimoto’s 
thyroiditis, participates in this reaction [Blanchin  et al., 2003]. The key antigen here is 
thyroid peroxidase. The TPO ectodomain consists of a long module similar to 
myeloperoxidase, followed by a module similar to the complement control protein (CCP) 
and a module similar to the epidermal growth factor (EGF). The CCP contains a fragment 
that activates the complement. Therefore, TPO can activate the complement cascade without 
the help of immunoglobulins. Tg Ab antibodies do not fix the complement [Weetmann et al., 
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2004] and probably are not directly involved in the CDC reaction, which is related to the fact 
that thyroglobulin is not expressed on the surface of thyrocytes. 
Reduction or loss of intercellular communication in the final phase of Hashimoto’s 
thyroiditis may lead to destruction of thyrocytes and hypothyroidism [Greek et al., 1996, 
Green et al., 1997, DiMatola  et al., 2000] 
 Fibrocytes and fibroblasts in autoimmune thyroid diseases  
Fibrocytes and fibroblasts are frequently disregarded in analyses of autoimmune reactions 
in the thyroid. Ultrastructural studies have revealed significant participation of fibroblasts in 
the pathogenetic processes in Hashimoto's disease. They enter the space between the basal 
membrane and thyrocytes and produce substantial amounts of collagen, thus leading to 
thickening of the basal membrane and impeded contact between the capillary vessel lumen 
and thyrocytes [Fig. 1,2].  
Influx and proliferation of lymphocytes in the thyroid as well as production of collagen is a 
response to inflammation processes and a stimulus for further thyrocyte damage through 
isolation thereof from oxygen and nutrients in the blood vessels. Progressive damage of 
thyrocytes leads to release of large amounts of autoantigen and triggers the inflammatory 
response. Own observations indicate a possible direct impact of plasma cells, lymphocytes 
and fibroblasts, since thyroids of Hashimoto’s thyroiditis patients exhibit close contact 
between the groups of lymphocytes, plasma cells and fibroblasts. 
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